Related Experiment Video
Updated: Jun 26, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Mammalian target of rapamycin complex 1: signalling inputs, substrates and feedback mechanisms
1Institute of Medical Genetics, Cardiff University, Heath Park, Cardiff, Wales, UK.
Abstract:
The mammalian target of rapamycin (mTOR) signalling pathway is implicated in the pathogenesis of a number of cancers and inherited hamartoma syndromes which have led to mTOR inhibitors, such as rapamycin, being tested in clinical trials. Knowledge of the mTOR pathway is rapidly expanding. This review provides an update on the most recent additions to the mTOR pathway with particular emphasis on mTORC1 signalling. mTORC1 signalling is classically known for its role in regulating cell growth and proliferation through modulation of protein synthesis. Recent research has identified novel mTORC1 cell signalling mechanisms that modulate mitochondrial biogenesis, hypoxia signalling and cell cycle progression and uncovered novel mTORC1 targets; YY1, HIF and SGK1. It is unsurprising that regulation of mTORC1 is multifaceted with many positive and negative signalling inputs. We discuss the recent advances that have been made to determine the upstream mechanisms that control mTORC1 through hypoxia, energy sensing and nutrient signalling. Also discussed are current findings that have unravelled a series of novel mTORC1-associated proteins that directly control the activity of mTORC1 and include PRAS40, FKBP38, Rag GTPases and RalA.
Insights
The mammalian target of rapamycin (mTOR) pathway, particularly mTORC1 signaling, is crucial in cancer and cell growth. Recent updates reveal new targets and regulators, expanding our understanding of its complex roles.
Area of Science:
- Cell Biology
- Molecular Biology
- Oncology
Background:
- The mammalian target of rapamycin (mTOR) signaling pathway is involved in cancer and inherited hamartoma syndromes.
- mTOR inhibitors like rapamycin are in clinical trials.
- Knowledge of the mTOR pathway is rapidly expanding.
Purpose of the Study:
- To provide an update on recent additions to the mTOR pathway.
- To emphasize mTORC1 signaling, its novel functions, and regulators.
- To discuss upstream mechanisms controlling mTORC1.
Main Methods:
- Literature review of recent research on the mTOR pathway.
- Focus on mTORC1 signaling mechanisms and targets.
- Analysis of upstream regulators and associated proteins.
Main Results:
- Novel mTORC1 signaling mechanisms modulate mitochondrial biogenesis, hypoxia signaling, and cell cycle progression.
- New mTORC1 targets identified include YY1, HIF, and SGK1.
- Novel mTORC1-associated proteins like PRAS40, FKBP38, Rag GTPases, and RalA have been uncovered.
Conclusions:
- mTORC1 signaling has multifaceted roles in cell growth, proliferation, and newly identified functions.
- Understanding upstream regulators (hypoxia, energy, nutrients) and associated proteins is key to controlling mTORC1 activity.
- This review highlights significant recent advances in mTOR pathway research.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades
Cell Signaling Feedback Loops
Negative feedback loops
Most signaling systems have negative feedback loops that can perform different functions such as output limiter, and adaptation.
Output limiter
Upon receiving an input signal, the cellular response rapidly increases until a threshold is reached. Beyond this threshold, a negative feedback loop...

